XOMA Royalty (XOMA) Debt Ratio (2010 - 2026)
XOMA Royalty (XOMA) reported Debt Ratio of 0.38 for Q1 2026, down 29.18% on a YoY basis from 0.53 in Q1 2025, and down 5.34% sequentially from 0.4 in Q4 2025.
XOMA Royalty (XOMA) Debt Ratio (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of Debt Ratio data on file, last reported at 0.38 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio fell 29.18% year-over-year to 0.38; the trailing twelve-month figure through Mar 2026 stood at 0.38 (down 29.18% YoY), and the FY2025 full-year result was 0.4, down 25.23% from the prior year.
- Debt Ratio fell to 0.38 in Q1 2026, from 0.4 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.55 in Q1 2024 to a low of 0.38 in Q1 2026.
- A 4-year average of 0.5 and a median of 0.53 in 2024 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio advanced 2.63% in 2025 and fell 29.18% in 2026, its largest moves.
- Tracing XOMA's Debt Ratio over 4 years: stood at 0.53 in 2023, then advanced by 0.94% to 0.53 in 2024, then fell by 25.23% to 0.4 in 2025, then retreated by 5.34% to 0.38 in 2026.
- Business Quant data shows XOMA's Debt Ratio at 0.38 in Q1 2026, 0.4 in Q4 2025, and 0.51 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.38 |
| Dec 31, 2025 | 0.40 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.53 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.53 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.55 |
| Dec 31, 2023 | 0.53 |
| Mar 31, 2021 | 0.16 |
| Dec 31, 2020 | 0.17 |
| Sep 30, 2020 | 0.35 |
| Jun 30, 2020 | 0.35 |
| Mar 31, 2020 | 0.34 |
| Dec 31, 2019 | 0.34 |
| Sep 30, 2019 | 0.38 |
| Jun 30, 2019 | 0.33 |
| Mar 31, 2019 | 0.30 |
| Dec 31, 2018 | 0.35 |
| Sep 30, 2018 | 0.48 |